Exercise medicine for metastatic castrate-resistant prostate cancer: a supervised, periodised, progressive and autoregulated program combining resistance and aerobic exercise - the INTERVAL-MCRPC prescription
Version 2 2024-06-03, 21:20Version 2 2024-06-03, 21:20
Version 1 2019-06-28, 14:08Version 1 2019-06-28, 14:08
conference contribution
posted on 2024-06-03, 21:20authored byRobert U Newton, Nicolas H Hart, Stacey A Kenfield, June M Chan, Kerry S Courneya, James Catto, Stephen P Finn, Rosemary Greenwood, Daniel C Hughes, Lorelei A Mucci, Stephen R Plymate, Michael N Pollak, Stephan FE Praet, Aaron RussellAaron Russell, Emer M Guinan, Erin L Van Blarigan, Orla Casey, Mark Buzza, Daniel A Galvao, Charles J Ryan, Fred Saad
Exercise medicine for metastatic castrate-resistant prostate cancer: a supervised, periodised, progressive and autoregulated program combining resistance and aerobic exercise - the INTERVAL-MCRPC prescription